Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001690177 | SCV001910565 | benign | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073226 | SCV002387427 | benign | Primary ciliary dyskinesia | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV001690177 | SCV002759526 | benign | not provided | 2019-11-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496009 | SCV002796517 | likely benign | X-linked cone-rod dystrophy 1; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness; Macular degeneration, X-linked atrophic | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001690177 | SCV004164816 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | RPGR: BP4, BS1, BS2 |
Victorian Clinical Genetics Services, |
RCV004594516 | SCV005086742 | likely benign | Macular degeneration, X-linked atrophic | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of macular degeneration, X-linked atrophic (MIM#300834), with 188 hemizygotes and 7 homozygotes in gnomAD v3. (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Breakthrough Genomics, |
RCV001690177 | SCV005276091 | benign | not provided | criteria provided, single submitter | not provided |